Multimeric antibodies with increased valency surpassing functional affinity and potency thresholds using novel formats.
View/ Open
Date
2020-01-01ICR Author
Author
Miller, A
Carr, S
Rabbitts, T
Ali, H
Type
Journal Article
Metadata
Show full item recordAbstract
The success of therapeutic antibodies is largely attributed for their exquisite specificity, homogeneity, and functionality. There is, however, a need to engineer antibodies to extend and enhance their potency. One parameter is functional affinity augmentation, since antibodies matured in vivo have a natural affinity threshold. Generation of multivalent antibodies is one option capable of surpassing this affinity threshold through increased avidity. In this study, we present a novel platform consisting of an array of multivalent antibody formats, termed Quads, generated using the self-assembling tetramerization domain from p53. We demonstrate the versatility of this tetramerization domain by engineering anti-tumor necrosis factor (TNF) Quads that exhibit major increases in binding potency and in neutralizing TNF-mediated cytotoxicity compared to parental anti-TNF molecules. Further, Quads are amenable to fusion with different binding domains, allowing generation of novel multivalent monospecific and bispecific formats. Quads are thus a novel group of molecules that can be engineered to yield potential therapeutics with novel modalities and potencies.
Collections
Research team
Chromosomal Translocations and Intracellular Antibody Therapeutics
Language
eng
License start date
2020-01
Citation
mAbs, 2020, 12 (1), pp. 1752529 - ?
Publisher
TAYLOR & FRANCIS INC